Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Pharmaceutical Statistics|April 3, 2024
A practical guide to the appropriate analysis of eGFR data over time: A simulation studyTodd DeVries, Kevin J Carroll, Sandra A LewisPharmaceutical Statistics|November 3, 2023
Conditional power and information fraction calculations at an interim analysis for random coefficient modelsSandra A Lewis, Kevin J Carroll, Todd DeVries, et al.Expert Review of Pharmacoeconomics & Outcomes Research|March 31, 2012
Successful implementation of cognitive interviews in special populationsCarla J DeMuro, Sandra A Lewis, Dana B DiBenedetti, et al.Journal of Clinical Pharmacology|April 18, 2018
Phase 1 First-in-Human, Single- and Multiple-Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus InfectionPolina German, Yan Xin, Jason W Chien, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 2, 2013
Inhaled aztreonam for chronic Burkholderia infection in cystic fibrosis: a placebo-controlled trialD Elizabeth Tullis, Jane L Burns, George Z Retsch-Bogart, et al.Thorax|October 18, 2014
Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scoresAlexandra L Quittner, Anne E O'Donnell, Matthias A Salathe, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 29, 2016
Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosisPatrick A Flume, John P Clancy, George Z Retsch-Bogart, et al.The Journal of Infectious Diseases|January 24, 2020
Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSVKirsten Stray, Michel Perron, Danielle P Porter, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 19, 2012
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trialBaroukh M Assael, Tacjana Pressler, Diana Bilton, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 3, 2013
Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: Phase 1 trial of GS-9411Thomas G O'Riordan, Karl H Donn, Peter Hodsman, et al.Pageof 2